Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F18%3A73593680" target="_blank" >RIV/61989592:15110/18:73593680 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1089/dia.2017.0283" target="_blank" >http://dx.doi.org/10.1089/dia.2017.0283</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1089/dia.2017.0283" target="_blank" >10.1089/dia.2017.0283</a>

Result language
angličtina
Original language name
Complex Assessment of Metabolic Effectiveness of Insulin Pump Therapy in Patients with Type 2 Diabetes Beyond HbA1c Reduction
Original language description
A total of 23 individuals with T2D (70% male). aged a mean+- standard deviation 57.2+-8.03 years with body mass index of 36.2+-7.02 kg/m2, diabetes duration of 13.3+-4.64 years, and HbA1c of 10.0%+-1.05% were randomly assigned to a CSII arm or an MDI continuation arm to explose glucose control, weight loss, total daily insulin dose (TDD), and insulin resistance. Insulin dosing was optimized over a 2-month run-in period. CSII therapy safely and significantly improved metabolic control with less insulin usage, with no sustainable reduction of BM, blood pressure, and lipid profile, in insulin-resistant T2D patients. Treatment adherence and satisfaction in these patients were excellent.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30202 - Endocrinology and metabolism (including diabetes, hormones)

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)